Efficacy and Safety of Chidamide in CBF Leukemia
Clinical trial NCT03031262 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03031262
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2025-04-10
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.